Important Limitations to Keep in Mind While promising, this research comes with important caveats: It still does not prove that semaglutide directly prevents dementia The findings apply only to people with Type 2 diabetes The exact mechanism of brain protection remains unclear For now, these results should be viewed as encouraging but not conclusive
A board-certified physician reviews your health history, goals, and prior treatment response before deciding whether a dual-pathway option is appropriate
What the SURMOUNT-4 Trial Tells Us The most direct evidence on stopping tirzepatide comes from the SURMOUNT-4 trial, published in JAMA in 2024
Environmental Pollution, 265 , Article 114980
Studies of Ozempic and Mounjaro have shown that both drugs are effective for this use
Healthy-Aging Goals Sermorelin is sometimes discussed in healthy-aging care, but age alone does not make someone a candidate